Clinical Trials Browser

Interventional × Carcinoma, Squamous Cell × olaparib × Clear all

NCT02308072 2026-05-22

ORCA-2

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT05366166 2026-01-28

Pembrolizumab Plus Olaparib in LA-HNSCC

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT02229656 2023-11-07

Olaparib and Radiotherapy in Head and Neck Cancer

Phase 1 Unknown

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms

NCT01491139 2012-05-30

ORCA

Phase 1 Withdrawn

Carcinoma, Squamous Cell